Genetic Testing & Carrier Screening Can Help Those Starting a Family
January 6, 2020
The Story of How One Woman Achieved Her Heart’s Desire
With the advances of genetic knowledge, couples should take advantage of integrating genetic testing into their reproductive decisions and options.
Couples can now check their carrier risk in order to avoid passing on unobserved genetic conditions, if any, to the next generation, and for couples going through IVF (in vitro fertilization), they can check the aneuploidy status of embryos prior to implantation to enable greater success.
It’s about helping IVF parents become more knowledgeable, showing them the risks, and providing them options so they can make the best, most informed decisions for their families.
Laurie Seiwert knows all too well what it means to go through this journey. Luckily, she used PTG-A and carrier screening and is now a mother of a beautiful little boy.
Reproductive Health within Thermo Fisher Scientific provides a comprehensive genetic analysis solutions for the reproductive lifecycles, from carrier screening research to preimplantation genetic testing for aneuploidy (PGT-A) and single gene mutation (PGT-M), to prenatal and postnatal research, as well as diagnostic tools for the detection of CNVs associated with developmental delays and/or intellectual disability, congenital anomalies, and/or dysmorphic features.
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.